Price F W, Whitson W E, Collins K S, Marks R G
Corneal Consultants of Indiana, Indianapolis 46260.
Arch Ophthalmol. 1993 Jun;111(6):799-805. doi: 10.1001/archopht.1993.01090060087029.
To determine the survival rates and causes of secondary graft failure in a large, consecutive series of penetrating keratoplasties.
All eyes undergoing penetrating keratoplasty at a single center were evaluated for factors relating to penetrating keratoplasty preoperatively, surgically, and postoperatively at 1, 3, 6, 9, 12, 18, and 24 months and then at yearly intervals. Since 1986, data analysis has been prospective.
A large, private practice, tertiary center for corneal disorders and surgery.
A consecutive series of 1819 penetrating keratoplasties performed from August 1982 through August 1990; 13 eyes with primary graft failure were excluded.
Graft failure and causes of failure. Follow-up ranged from 1 to 96 months, with a mean of 26.6 months.
Pseudophakic bullous keratopathy was the most common diagnosis necessitating keratoplasty (38.6%). Secondary failures occurred 111 times (6.1%). The 2- and 5-year survival rates for all grafts in the study were 95% and 91%, respectively. While endothelial failure as a result of immunologic allograft reactions was the most common cause of graft failure (27%), problems with the external surface of the graft caused nearly as many failures (25%). The risk of failure from surface-related problems was highest at 3 months after surgery. There were significantly decreased survival rates for grafts in eyes with regrafts (P < .0001), in eyes left aphakic at keratoplasty (P < .0001), and in eyes with deep stromal vascularization (P < .0001).
Penetrating keratoplasty is a successful form of transplantation, and survival rates are gradually increasing. The risk of graft failure appears highest within the first year after transplantation.
确定大量连续穿透性角膜移植术中二次移植失败的存活率及原因。
对在单一中心接受穿透性角膜移植术的所有眼睛,在术前、术中以及术后1、3、6、9、12、18和24个月进行评估,之后每年评估一次与穿透性角膜移植术相关的因素。自1986年起,数据分析为前瞻性研究。
一家大型私立角膜疾病与手术三级中心。
1982年8月至1990年8月连续进行1819例穿透性角膜移植术;排除13例原发性移植失败的眼睛。
移植失败及失败原因。随访时间为1至96个月,平均为26.6个月。
人工晶状体性大泡性角膜病变是需要进行角膜移植术最常见的诊断(38.6%)。二次移植失败发生111次(6.1%)。本研究中所有移植的2年和5年存活率分别为95%和91%。免疫同种异体移植反应导致内皮功能衰竭是移植失败最常见的原因(27%),移植眼外表面问题导致的失败次数几乎相同(25%)。与表面相关问题导致失败的风险在术后3个月时最高。再次移植的眼睛(P < .0001)、角膜移植术时无晶状体的眼睛(P < .0001)以及有深层基质血管化的眼睛(P < .0001)中移植的存活率显著降低。
穿透性角膜移植术是一种成功的移植形式,存活率在逐渐提高。移植失败的风险在移植后第一年似乎最高。